Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Revenue (2016 - 2025)

OptimizeRx (OPRX) has disclosed Revenue for 16 consecutive years, with $32.2 million as the latest value for Q4 2025.

  • Quarterly Revenue changed 0.24% to $32.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $109.4 million through Dec 2025, up 18.78% year-over-year, with the annual reading at $109.4 million for FY2025, 18.78% up from the prior year.
  • Revenue hit $32.2 million in Q4 2025 for OptimizeRx, up from $26.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $32.3 million in Q4 2024 to a low of $11.2 million in Q1 2021.
  • Historically, Revenue has averaged $19.8 million across 5 years, with a median of $19.2 million in 2022.
  • Biggest five-year swings in Revenue: decreased 6.45% in 2022 and later skyrocketed 55.19% in 2025.
  • Year by year, Revenue stood at $20.3 million in 2021, then fell by 3.24% to $19.7 million in 2022, then skyrocketed by 44.34% to $28.4 million in 2023, then rose by 13.91% to $32.3 million in 2024, then decreased by 0.24% to $32.2 million in 2025.
  • Business Quant data shows Revenue for OPRX at $32.2 million in Q4 2025, $26.1 million in Q3 2025, and $29.2 million in Q2 2025.